Skip to content
HowShorted

COLLEGIUM PHARMACEUTICAL, INC short interest in 2019

In 2019, COLLEGIUM PHARMACEUTICAL, INC's disclosed short interest ran from 9.12% of shares outstanding on 15 Jan 2019 to 6.07% on 31 Dec 2019, a change of -3.05 percentage points. The year's high was 9.29% on 15 Jul 2019 and its low 4.95% on 13 Dec 2019, averaging 7.82% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.01 days on 30 Aug 2019. Full history: COLLEGIUM PHARMACEUTICAL, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for COLLEGIUM PHARMACEUTICAL, INC in 2019

2019 in figures

Start of year
9.12% (15 Jan 2019)
End of year
6.07% (31 Dec 2019)
Change
-3.05 pp
High
9.29% (15 Jul 2019)
Low
4.95% (13 Dec 2019)
Average
7.82%
Highest days to cover
16.01 (30 Aug 2019)
SEC filings marked
8

Every report in 2019

COLLEGIUM PHARMACEUTICAL, INC short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20199.12%4.72
31 Jan 20198.62%11.55
15 Feb 20197.88%6.51
28 Feb 20197.48%4.5110-K filed, results (8-K)
15 Mar 20198.19%5.43
29 Mar 20198.74%6.63
15 Apr 20196.52%6.15
30 Apr 20197.46%7.48
15 May 20198.31%7.5110-Q filed, results (8-K)
31 May 20198.28%7.93
14 Jun 20198.65%8.74
28 Jun 20198.71%7.14
15 Jul 20199.29%13.90
31 Jul 20198.72%10.58
15 Aug 20198.55%10.7310-Q filed, results (8-K)
30 Aug 20199.01%16.01
13 Sep 20198.39%8.82
30 Sep 20198.21%8.58
15 Oct 20197.97%9.13
31 Oct 20197.31%5.63
15 Nov 20195.52%2.3710-Q filed, results (8-K)
29 Nov 20195.73%4.68
13 Dec 20194.95%5.65
31 Dec 20196.07%6.49

See also: COLLEGIUM PHARMACEUTICAL, INC's full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.